Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases fromMycobacterium tuberculosis
- 3 January 2012
- journal article
- other
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 28 (2) , 384-387
Abstract
A series of halogenated sulfanilamides and halogenated benzolamide derivatives have been investigated as inhibitors of three β-carbonic anhydrases (CAs, EC 4.2.1.1) from the bacterial pathogen Mycobacterium tuberculosis, mtCA 1 (Rv1284), mtCA 2 (Rv3588c) and mtCA 3 (Rv3273). All three enzymes were inhibited with efficacies between the submicromolar to the micromolar one, depending on the substitution pattern at the sulfanilamide moiety/fragment of the molecule. Best inhibitors were the halogenated benzolamides (KIs in the range of 0.12–0.45 μM) whereas the halogenated sulfanilamides were slightly less inhibitory (KIs in the range of 0.41–4.74 μM). This class of β-CA inhibitors may have the potential for developing antimycobacterial agents with a diverse mechanism of action compared to the clinically used drugs for which many strains exhibit multi-drug/extensive multi-drug resistance.Keywords
This publication has 28 references indexed in Scilit:
- Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar TyphimuriumBioorganic & Medicinal Chemistry Letters, 2011
- Characterization and inhibition studies of an α-carbonic anhydrase from the endangered sturgeon speciesAcipenser gueldenstaedtiJournal of Enzyme Inhibition and Medicinal Chemistry, 2011
- Bacterial Carbonic Anhydrases as Drug Targets: Toward Novel Antibiotics?Frontiers in Pharmacology, 2011
- Carbonic anhydrase inhibitorsBioorganic & Medicinal Chemistry Letters, 2010
- Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588cBioorganic & Medicinal Chemistry Letters, 2009
- Carbonic Anhydrase Inhibitors. Cloning, Characterization, and Inhibition Studies of a New β-Carbonic Anhydrase from Mycobacterium tuberculosisJournal of Medicinal Chemistry, 2009
- Structure and Inhibition of the CO2-Sensing Carbonic Anhydrase Can2 from the Pathogenic Fungus Cryptococcus neoformansJournal of Molecular Biology, 2009
- Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosisNature Reviews Microbiology, 2009
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activatorsNature Reviews Drug Discovery, 2008
- Review ArticleJournal of Enzyme Inhibition and Medicinal Chemistry, 2004